Targeting axonal transport in Alzheimer's disease webinar

Overview

What makes a good potential target for drug discovery?

Listen in as Dr Elizabeth Glennon, of King's College London, discusses how the disruption of axonal transports early on within Alzheimer's Disease provides excellent targets for drug discovery.

Topics

How disruption of axonal transport contributes to the development of Alzheimer's disease

Mechanisms of axonal transport of the Alzheimer's amyloid precursor protein, and how these are altered in the disease

Watch now

Professional Email Address*

Country / Region*

^{^{Abcam will process your personal data in strict accordance with its privacy policy which can be found here. This will include sending you updates about Abcam, our products, and resources we think would be of interest to you. You can unsubscribe and manage your marketing preferences by clicking the link at the bottom of every email we send. By filling out this form you consent to Abcam sharing your details with your local, authorized distributor for the purpose of answering your query.}}

Meet our presenter

Meet our presenter

Elizabeth Glennon

Elizabeth (Lizzie) Glennon studied her degree in biochemistry at the University of York (UK), followed by a PhD at the Univeristy of Leeds (UK), where she studied molecular mechanisms of neurodegeneration in Alzheimer's disease. Lizzie subsequently moved to King's College London, where she worked as a post doc investigating how a break down in axonal transport may contribute to development of Alzheimers disease.